#116 – AMA with Dom D’Agostino, Ph.D., Part I of II: Ketogenic diet, exogenous ketones, and exercise
“If you restore insulin sensitivity, you’re better able to access and burn fat.” — Dom D’Agostino
#114 – Eileen White, Ph.D.: Autophagy, fasting, and promising new cancer therapies
“I would like to translate what we’ve learned about the role of autophagy in cancer and that involves developing small molecules to inhibit autophagy for cancer therapy.” — Eileen White
Alzheimer’s disease and glucose metabolism
“In Alzheimer’s Research, Glucose Metabolism Moves to Center Stage.”
LDL-C & systolic blood pressure and lifetime risk of cardiovascular disease
Mendelian randomization and lifetime cardiovascular disease risk.
Qualy #24 – What are the “ABCs” of Alzheimer’s prevention?
Today’s episode of The Qualys is from podcast #18 – Richard Isaacson, M.D.: Alzheimer’s prevention.
Qualy #16 – How much does cognitive activity ward off cognitive decline?
Today’s episode of The Qualys is from podcast #18 – Richard Isaacson, M.D.: Alzheimer’s prevention.
What can you prove?
If that weren’t enough to set me off, consider the overall weakness of this study, and the choice of the word “proven” borders on journalistic manslaughter.
#66 – Vamsi Mootha, M.D.: Aging, type 2 diabetes, cancer, Alzheimer’s disease, and Parkinson’s disease – do all roads lead to mitochondria?
“We have 300 different forms of monogenic mitochondrial diseases. . .and these are terrible diseases and we need therapies for them. . .but it’s also our hope that studying some of them will provide insights into the common form of aging as well.” —Vamsi Mootha
#58 – AMA with sleep expert, Matthew Walker, Ph.D.: Strategies for sleeping more, sleeping better, and avoiding things that are disrupting sleep
“[Sleep] is like that master volume button on a mixing deck that you see in the studio. You can manipulate each one of those dials, or you can go to the far left and just move that one dial…and all of the other levers seem to move with it.” — Matthew Walker
A hidden blockbuster drug for Alzheimer’s disease?
How, you might ask, can a company withhold information about a drug that could potentially prevent such a devastating disease?